EyeOnIPPatents, Trademarks, Trade Secrets, and Copyrights Oh My!
|COVID-19 vaccine patent battles continue into 2023|
|"A tangle of high-stakes U.S. patent disputes over COVID-19 vaccines could be tamed by court rulings or grow even more complex...Pfizer earned over $26.4 billion from sales of its vaccines in... 2022, while Moderna sold over $13.5 billion."|
| 2023-01-02 06:15:37 |